OR10Q2P

Across TCGA pan-cancer cohorts, OR10Q2P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR10Q2P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher OR10Q2P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated OR10Q2P expression acts as an unfavorable survival marker.

ACC, KIRP, and BRCA are the cancer types where OR10Q2P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.046	0.753	<.001	72	view →
KIRP	OS	Tertile	II,III,IV	0.161	0.771	.002	45	view →
BRCA	DFS	Tertile	IV	0.175	0.730	.005	36	view →
THYM	DFS	Tertile	All	0.607	0.910	.005	36	view →
UCEC	OS	Tertile	All	0.901	0.927	.041	24	view →
KIRC	DFS	Tertile	All	0.638	0.827	<.001	18	view →
THCA	OS	Tertile	IV	0.520	0.840	.020	18	view →
GBM	DFS	Tertile	All	0.071	0.288	.009	18	view →
HNSC	DFS	Tertile	II,III,IV	0.244	0.563	.024	18	view →
SARC	OS	Tertile	All	0.022	0.861	<.001	18	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR10Q2P–ACC (DFS)

Open the ACC breakdown →